Sterile Erythromycin Gluceptate Analysis Service

Sterile Erythromycin Gluceptate Analysis Service

Our Reliable Sterile Erythromycin Gluceptate Analysis Service

CD BioGlyco offers a specialized sterile erythromycin gluceptate analysis service as part of our comprehensive Pharmaceutical Analysis Service, which is an integral component of our Pharmaceutical and Biological Analysis Service. This service is designed to provide accurate and reliable analysis for sterile erythromycin gluceptate, ensuring its quality and adherence to specific requirements.

Erythromycin gluceptate, a macrolide antibiotic derived from the actinomycete Streptomyces erythreus, demonstrates a broad spectrum of antimicrobial activity. By binding to bacterial 50S ribosomal subunits, it impedes RNA-dependent protein synthesis through the obstruction of transpeptidation and/or translocation reactions, without impacting nucleic acid synthesis. Beyond its antibiotic properties, erythromycin gluceptate showcases antitumor and neuroprotective effects, contributing to diverse areas of research.

Fig.1 The structure of erythromycin gluceptate. (CD BioGlyco)Fig.1 The structure of erythromycin gluceptate. (CD BioGlyco)

Our sterile erythromycin gluceptate analysis service is capable of testing various formulations shown below. We employ mature experimental protocols to ensure precise and reliable analysis of these formulations. Our robust capabilities and well-established methodologies contribute to the accuracy and quality of our analytical services.

Fig.2 The preparations of erythromycin gluceptate can be analyzed. (CD BioGlyco)Fig.2 The preparations of erythromycin gluceptate can be analyzed. (CD BioGlyco)

Our comprehensive testing includes rigorous assessments such as sterility testing, pH testing, dissolution testing, and more. These analyses are crucial for confirming the purity, potency, and overall quality of sterile erythromycin gluceptate and related formulations.

Table 1. The test items included in the erythromycin gluceptate analysis service. (CD BioGlyco)

Sterile erythromycin gluceptate
  • Identification with infrared absorption method
  • Bacterial endotoxin test
  • Sterility test
  • pH test
  • Water content test
  • Particulate matter test
  • Antibiotics—Microbial assay
Erythromycin lactobionate for injection
  • Identification with infrared absorption method
  • Bacterial endotoxin test
  • pH test
  • Water content test
  • Particulate matter content test
  • Heavy metal content test
  • Antibiotics—Microbial assay
Sterile erythromycin lactobionate
  • Identification with infrared absorption method
  • Bacterial endotoxin test
  • Sterility test
  • pH test
  • Water content test
  • Particulate matter test
  • Heavy metal test
Erythromycin stearate
  • Identification with infrared absorption method
  • Crystallinity test
  • Water content test
  • Related compound test
Erythromycin stearate tablets
  • Identification with infrared absorption method
  • Dissolution test
  • Uniformity of dosage unit test
  • Loss on drying test

Publication Data

Title: Erythromycin formulations—a journey to advanced drug delivery

Technology: Liposomes, Solid–lipid nanoparticles, Mesoporous oxides, Metallic-based nanoparticles

Journal: Pharmaceutics

IF: 5.4

Published: 2022

Results: Erythromycin, a broad-spectrum macrolide, has been pivotal in treating various bacterial infections since its discovery in 1952. However, challenges like low solubility and instability prompted diverse erythromycin formulations, including nanoparticles. This review comprehensively assesses efforts to encapsulate erythromycin in formulations, detailing their chemical compositions, sizes, morphologies, and physico-chemical properties. Despite the promising outcomes, the work emphasizes the existing limitations, particularly in erythromycin quantification, underscoring the need for further research.

Applications

  • Our sterile erythromycin gluceptate analysis service confirms the sterility of formulations, which is crucial for preventing microbial contamination during production.
  • Our sterile erythromycin gluceptate analysis service assesses the stability of sterile erythromycin gluceptate formulations under different storage conditions to ensure product integrity.
  • Our sterile erythromycin gluceptate analysis service verifies the uniform distribution of erythromycin gluceptate within formulations, ensuring consistent dosage across individual units.
  • Our sterile erythromycin gluceptate analysis service ensures that formulations meet a specific requirement.

Advantages

  • We access state-of-the-art technology and methodologies for advanced glycan analysis, ensuring the use of the latest tools in the field.
  • Our services find applications not only in pharmaceuticals but also in biomarker development, vaccine research, and various other areas within the life sciences.
  • We have experienced excellent client support, with a dedicated team ready to address queries, provide guidance, and facilitate smooth project execution.

At CD BioGlyco, we provide comprehensive sterile erythromycin gluceptate analysis service, offering excellent pharmaceutical analysis solutions. With well-established experimental protocols, our professional team ensures accurate and reliable results for your project. Please feel free to contact us for more details and ask for a custom analysis solution.

Reference

  1. Platon, V.M.; et al. Erythromycin formulations—a journey to advanced drug delivery. Pharmaceutics. 2022, 14(10): 2180.
This service is for Research Use Only, not intended for any clinical use.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.